USC researchers are evaluating a blood test that detects tumor-associated extracellular vesicles and rare cancer cells, potentially improving early breast cancer detection alongside mammography...
Read More »
A new tyramide-based fluorescence technique enhances detection of extracellular vesicles, improving liquid biopsy analysis and cancer...
Read More »
Extracellular vesicles called shearosomes are released by circulating tumor cells as they squeeze through capillaries, influencing blood vessels and...
Read More »
Extracellular vesicles, including exosomes, are emerging as key biomarkers in liquid biopsy approaches that offer real-time, noninvasive insights to guide immunotherapy and improve lung...
Read More »
A new bioelectronic device captures tumor cells with high efficiency and uses electrical stimulation to enhance extracellular vesicles production...
Read More »
Liquid biopsy analyzes circulating biomarkers like extracellular vesicles to detect cancer early, offering a non-invasive and dynamic alternative to tissue...
Read More »
Graphene-based materials are intriguing nanomaterials with applications ranging from nanotechnology-related devices to drug delivery systems and biosensing. Multifunctional graphene platforms were proposed for the detection of several...
Read More »
In recent years, there has been an increase in knowledge of cancer, accompanied by a technological development that gives rise to medical oncology. An instrument that allows the...
Read More »
The term ‘liquid biopsy’, introduced in 2013 in reference to the analysis of circulating tumour cells (CTCs) in cancer patients, was extended to cell-free nucleic acids (cfNAs) circulating in blood and other body fluids. CTCs and cfNAs are now considered ...
Read More »
The term liquid biopsy refers to the use of blood and other bodily fluids as a surrogate of tissue samples for diagnostic purposes. The rationale for using liquid biopsies instead of actual tissue samples...
Read More »
Exosome RNA Exosome RNA Research & Industry News
